Mission Cure Capital
Mission Cure Capital (MCC) is the first and only mission-driven impact investment company focused on Pancreatitis. MCH invests in commercially-promising research and development projects that will improve the lives of children and adults suffering from pancreatitis. Pancreatitis is a genetically-driven, debilitating disease that causes inflammation and severe pain and leads to digestive dysfunction, diabetes and an increased risk of pancreatic cancer. Chronic and recurrent acute pancreatitis affects over people in the United States alone plus millions more worldwide. There are currently no effective treatments or cures but with clear priorities and our focused investment strategy, we intend to change that.
7-day free trial · no credit card
Verified contacts
1
available on Kipplo
LinkedIn employees
1
1 to 10 range
Open roles
—
no listings
Distinct roles
1
indexed titles
Tech stack
1
tools in use
Monthly traffic
—
organic / mo
Sign up free to see all 1 verified contacts at Mission Cure Capital
Free for 7 days · 50 credits · no card · only pay for verified records.
Decision-makers and verified team members
1 contacts with verified email or phone · masked until revealed.
Showing 1 of 1 verified contacts
Top roles at Mission Cure Capital
1 distinct titles indexed · top 1 shown.
- 1president
Sign up to unlock all 1 contacts at Mission Cure Capital
Free for 7 days · 50 credits · no card · only pay for verified records.
Sign up to reveal 1 verified contacts at Mission Cure Capital
7-day trial · no credit card · cancel anytime · only pay for verified records.
Trusted by sales, marketing, and GTM engineering teams.